-
1.发明公开SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING APLINDORE AND DERIVATIVES THEREOF 有权APLINDOR及其衍生物具有药学持续释放组合物
公开(公告)号：EP1675583A1
公开(公告)日：2006-07-05
申请号：EP04818331.3
申请日：2004-10-28
申请人： Wyeth
CPC分类号： A61K31/407 , A61K9/2054 , A61K9/2866
摘要： or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
-
2.发明授权SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING APLINDORE AND DERIVATIVES THEREOF 有权APLINDOR及其衍生物具有药学持续释放组合物
公开(公告)号：EP1675583B1
公开(公告)日：2013-02-27
申请号：EP04818331.3
申请日：2004-10-28
申请人： Wyeth LLC
CPC分类号： A61K31/407 , A61K9/2054 , A61K9/2866
摘要： or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
-
公开(公告)号：EP1819322A2
公开(公告)日：2007-08-22
申请号：EP05852605.4
申请日：2005-11-30
申请人： Wyeth
IPC分类号： A61K9/20 , A61K31/4164 , A61K9/50 , A61K31/4184 , A61K9/28 , A61K31/423 , A61K9/48
CPC分类号： A61K9/1611 , A61K9/1635 , A61K9/20 , A61K9/28 , A61K9/48 , A61K9/4858 , A61K31/4164 , A61K31/4184 , A61K31/423 , A61K31/428
摘要： The present invention provides solid dosage formulations of benzoxazole-containing ERβ-selective ligands, and processes for their manufacture.
摘要翻译： 本发明提供含有苯并恶唑的ERβ选择性配体的固体剂型及其制造方法。
-
-
搜索结果
3 条记录 (耗时 0.009 秒)
